Molecular Diagnosis and Identification of Novel Pathogenic Variants in a Large Cohort of Italian Patients Affected by Polycystic Kidney Diseases

• Published in: Genes Vol. 14; no. 6; p. 1236
• Main Authors: Nigro, Ersilia, Amicone, Maria, D'Arco, Daniela, Sellitti, Gina, De Marco, Oriana, Guarino, Maria, Riccio, Eleonora, Pisani, Antonio, Daniele, Aurora
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.06.2023; MDPI
• Subjects: ADPKD; ARPKD; Bar codes; Chromosomes; Custom design; Cysts; Diagnosis; DNA sequencing; Ethylenediaminetetraacetic acid; Exons; Family medical history; Gene mutations; Genes; Genes, Regulator; Genetic aspects; genetic complexity; Genetic counseling; Genetic testing; Genomes; Hereditary diseases; Humans; Instrument industry; Kidney diseases; Mutation; next-generation sequencing; Nucleotide sequencing; Patients; Phenotypes; Polycystic kidney; Polycystic kidney disease 1 protein; polycystic kidney diseases; Polycystic Kidney, Autosomal Dominant - diagnosis; Polycystic Kidney, Autosomal Dominant - genetics; Polycystic Kidney, Autosomal Recessive - diagnosis; Polycystic Kidney, Autosomal Recessive - genetics; Transcription Factors - genetics; TRPP Cation Channels - genetics; United States; Netherlands; California; United States > US; Italy; ADPKD; ARPKD; polycystic kidney diseases; next-generation sequencing; genetic complexity
• ISSN: 2073-4425; 2073-4425
• DOI: 10.3390/genes14061236

Polycystic Kidney Diseases (PKDs) consist of a genetically and phenotypically heterogeneous group of inherited disorders characterized by numerous renal cysts. PKDs include autosomal dominant ADPKD, autosomal recessive ARPKD and atypical forms. Here, we analyzed 255 Italian patients using an NGS panel of 63 genes, plus Sanger sequencing of exon 1 of the gene and MPLA ( and ) analysis. Overall, 167 patients bore pathogenic/likely pathogenic variants in dominant genes, and 5 patients in recessive genes. Four patients were carriers of one pathogenic/likely pathogenic recessive variant. A total of 24 patients had a VUS variant in dominant genes, 8 patients in recessive genes and 15 patients were carriers of one VUS variant in recessive genes. Finally, in 32 patients we could not reveal any variant. Regarding the global diagnostic status, 69% of total patients bore pathogenic/likely pathogenic variants, 18.4% VUS variants and in 12.6% of patients we could not find any. and resulted to be the most mutated genes; additional genes were and . Among recessive genes, was the most mutated gene. An analysis of eGFR values showed that patients with truncating variants had a more severe phenotype. In conclusion, our study confirmed the high degree of genetic complexity at the basis of PKDs and highlighted the crucial role of molecular characterization in patients with suspicious clinical diagnosis. An accurate and early molecular diagnosis is essential to adopt the appropriate therapeutic protocol and represents a predictive factor for family members.